Medical Health & Life Science Research News

Discover the prostate cancer therapeutics global market forecast to 2023

Increase in prostate cancer cases in recent years and raise in development of innovative drugs are the some of the prominent factors driving the market growth. Whereas high cost and low success rate in the clinical test are hampering the market.

- Advertising -

However, increase in geriatric population and increase in R&D expenditure in this market seems to be opportunity for the market growth. In 2016, North America accounted for the highest market share owing to increase in research and development expenditure.

- Advertising -

The Asia Pacific region is expected to grow at a higher CAGR and is anticipated to account for the highest market share during forecast period because of government initiatives on creating awareness on prostate cancer.

For more information about this report: www.reportsweb.com/prostate-cancer…outlook-2017-2023

Some of the key players in the market include Tolmar Inc, Teva Pharmaceutical Industries Ltd, Takeda Pharmaceutical Co. Ltd, Sanofi-Aventis, Pfizer Inc, Johnson & Johnson, Ipsen, Ferring Pharmaceuticals, Endo Pharmaceuticals Inc (Indevus Pharmaceuticals Inc), Dendreon Corporation, Bristol-Myers Squibb, Astrazeneca Plc, Astellas Pharma Inc, Active Biotech and Abbott Laboratories.

Drugs Classes Covered:
-Chemotherapy
- Estramustine (Emcyt)
- Mitoxantrone (Novantrone)
- Jevtana
- Taxotere
-Targeted Therapy
- Xofigo
-Hormonal Therapy
- Anti-Androgens
- Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists
- Luteinizing Hormone-Releasing Hormone (LHRH) Analogs
-Immunotherapy
- Provenge

Distribution Channels Covered:
-Hospital Pharmacy
-Retail Pharmacy
-Online Sales
-Other Distribution Channels

Request Sample Copy at www.reportsweb.com/inquiry&RW0001888512/sample

Regions Covered:
-North America
- US
- Canada
- Mexico
-Europe
- Germany
- France
- Italy
- UK 
- Spain 
- Rest of Europe 
-Asia Pacific
- Japan 
- China 
- India 
- Australia 
- New Zealand 
- Rest of Asia Pacific 
-Rest of the World
- Middle East
- Brazil
- Argentina
- South Africa
- Egypt

Company Profiling 
9.1 Tolmar Inc 
9.2 Teva Pharmaceutical Industries Ltd 
9.3 Takeda Pharmaceutical Co. Ltd 
9.4 Sanofi-Aventis 
9.5 Pfizer Inc 
9.6 Johnson & Johnson 
9.7 Ipsen 
9.8 Ferring Pharmaceuticals 
9.9 Endo Pharmaceuticals Inc (Indevus Pharmaceuticals Inc) 
9.10 Dendreon Corporation 
9.11 Bristol-Myers Squibb 
9.12 Astrazeneca Plc 
9.13 Astellas Pharma Inc 
9.14 Active Biotech 
9.15 Abbott Laboratories 

Inquire report at www.reportsweb.com/inquiry&RW0001888512/buying

News From

ReportsWeb - Market Research ReportsReportsWeb
Category: Market Research Publishers and RetailersCompany profile: ReportsWeb is a one-stop shop for market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost-effective research papers and solutions from various publishers. The market research industry has changed in last decade. As the corporate focus has shifted to niche markets and emerging countries, some publishers have stepped in to fulfill these information needs. We have experienced and ...